Wednesday, October 7, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 15, 2026

5 of the Safest Growth Stocks You Can Confidently Buy for 2026

View original at nasdaq.com
5 of the Safest Growth Stocks You Can Confidently Buy for 2026 Key Points The benchmark S&P 500 delivered its third consecutive year of gains at or above 15% in 2025…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Meta could modestly pare back its aggressive AI spending and blow analysts' earnings per share estimates out of the water

    80% confidence
  • Over the last eight decades, the average U.S. recession has lasted approximately 10 months, while the typical economic expansion has persisted for around five years

    80% confidence
  • Hackers don't take holidays from trying to access and steal sensitive information, making cybersecurity solutions a basic necessity

    80% confidence
  • The incorporation of generative AI solutions into Meta's social media advertising platforms is generating positive results by enabling businesses to tailor messages for individual users

    80% confidence
  • Visa and Mastercard are solely focused on payment processing and aren't lenders, so there's no need to set aside capital for credit delinquencies and loan losses

    80% confidence
  • Stock Advisor's total average return is 970%, a market-crushing outperformance compared to 197% for the S&P 500

    80% confidence
  • The stock market is historically pricey based on more than 150 years of historical trends from the Shiller P/E Ratio, showing that Wall Street's benchmark index swoons 20% or more when it becomes expensive

    80% confidence
  • Services powered by AI and ML tend to be nimbler than on-premises solutions, leading to faster recognition of potential threats

    80% confidence
  • No other social media platform comes close to Meta's 3.54 billion daily active users figure, enabling Meta to charge a hearty premium for ad placement

    80% confidence
  • If credit card interest rates are capped, it would likely encourage consumers and businesses to lean on credit even more, leading to higher merchant fees collected by Visa and Mastercard

    80% confidence
  • Most emerging markets remain underbanked, providing Visa and Mastercard with opportunities to sustain their double-digit sales growth for the long term

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,362 source documents archived
Query this data → isubstrate.com